Annals meeting reports
Contributors: The Interdisciplinary Science of Consumption: Mechanisms of Allocating Resources Across Disciplines (2010 : Ann Arbor, Mich.); Wild Immunology (2011 : University of Edinburgh); Advancing Drug Discovery for Schizophrenia (2011 : New York Academy of Sciences)
Series: Annals of the New York Academy of Sciences -- v. 1236; Annals of the New York Academy of Sciences -- v. 1236.
Publisher: Published by Blackwell Pub. on behalf of the New York Academy of Sciences
Published: 2011
Place of publication: Boston, Mass
Language: eng
Number of pages: 43
ISBN-13: 9781573318532
Subjects: Immunology; Psychology; Consumers; Schizophrenia; Consumer behavior; Congresses; Treatment; Chemotherapy
Description: Scientific perspectives on the drive to consume were presented in Ann Arbor, Mich., at the conference entitled "The Interdisciplinary Science of Consumption: Mechanisms of Allocating Resources Across Disciplines." The meeting, which took place May 12-15, 2010 and was sponsored by Rackham Graduate School and the Dept. of Psychology at the University of Michigan, included presentations on human, primate, and rodent models and spanned multiple domains of consumption, including reward seeking, delay discounting, food-sharing reciprocity, and the consumption and display of material possessions across the life span.

The Centre for Immunity, Infection and Evolution sponsored a one-day symposium at the University of Edinburgh on 30 June 2011 entitled "Wild Immunology." The central question of the symposium was, "Why should we try to understand infection and immunity in wild systems?" Specifically, how does the immune response operate in the wild and how do multiple coinfections and commensalism affect immune responses and host health in these wild systems?--

Sponsored by the New York Academy of Sciences and with support from the National Institute of Mental Health, the Life Technologies Foundation, and the Josiah Macy Jr. Foundation, "Advancing Drug Discovery for Schizophrenia" was held Mar. 9-11, 2011 at the New York Academy of Sciences in New York City. The meeting, comprising individual talks and panel discussions, highlighted basic, clinical, and translational research approaches, all of which contribute to the overarching goal of enhancing the pharmaceutical armamentarium for treating schizophrenia. This report surveys work by the vanguard of schizophrenia research in such topics as genetic and epigenetic approaches; small molecule therapeutics; and the relationships between target genes, neuronal function, and symptoms of schizophrenia.
Notes: Includes bibliographical references.
Table of contents: title: Toward an interdisciplinary science of consumption  -- Stephanie D. Preston; title: Wild immunology : converging on the real world  -- Simon A. Babayan ... [et al.]; title: Advancing drug discovery for schizophrenia -- Stephen R. Marder ... [et al.].